Oncternal Therapeutics, Inc. (ONCT) Social Stream



Oncternal Therapeutics, Inc. (ONCT): $8.40

0.20 (+2.44%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ONCT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#131 of 363

in industry

ONCTERNAL THERAPEUTICS INC (ONCT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ONCT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-26 4 $21 $9 $15.5 $0.536 2791.79%
2022-05-06 4 $16 $9 $14 $0.536 2511.94%
2022-05-27 5 $15 $8 $12.25 $0.536 2185.45%
2022-07-15 5 $15 $3.5 $10.5 $0.536 1858.96%
2022-09-27 5 $15 $3.5 $10.3 $0.536 1821.64%
2022-12-12 4 $15 $3.5 $9.875 $0.536 1742.35%
2022-12-22 5 $15 $3.5 $8.7 $0.536 1523.13%
2023-03-10 6 $15 $3.5 $8.7 $0.536 1523.13%
2023-03-14 5 $15 $3.5 $8.25 $0.536 1439.18%
2023-03-22 6 $15 $3.5 $7.416 $0.536 1283.58%
2023-04-04 6 $4 $2.5 $3.333 $0.536 521.83%
2023-08-14 6 $2.5 $1.3 $1.9 $0.536 254.48%
2023-09-18 6 $2.5 $1.3 $1.933 $0.536 260.63%
2023-10-27 5 $2.5 $2 $2.25 $0.536 319.78%
2023-11-10 4 $2.5 $2 $2.25 $0.536 319.78%
2023-12-04 4 $2.5 $2 $2.166 $0.536 304.1%

The Trend in the Analyst Price Target


ONCT's average price target has moved down $8.33 over the prior 57 months.

Over the past 38 weeks, ONCT's average upside potential has been 690.43%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-10 6 15.0 3.5 8.250 0.750 1000%
2023-03-14 5 15.0 3.5 8.250 0.738 1017.89%
2023-03-22 6 15.0 3.5 7.416 0.706 950.42%
2023-05-05 6 2.5 1.3 1.900 0.330 475.76%
2023-10-27 5 2.5 2.0 2.250 0.320 603.12%

ONCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 31 weeks, ONCT's average broker recommendation rating improved by 1.17.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how ONCTERNAL THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1822.79% of that group.
  • In terms of how ONCTERNAL THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 140.54% of that group.
  • ONCT has a lower variance in analysts' estimates than -1284.59% of stocks in the small market cap category.
  • In the context of Healthcare stocks, ONCTERNAL THERAPEUTICS INC's number of analysts covering the stock is higher than 511.11% of them.

In the Pharmaceutical Products industry, MTEM, LUMO, and CPIX are the three stocks most similar to ONCTERNAL THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for ONCT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!